Opus Genetics, Valuation
| IRD Stock | 1.11 0.17 18.09% |
Today, the company appears to be overvalued. Opus Genetics, holds a recent Real Value of USD0.95 per share. The prevailing price of the company is USD1.11. Our model determines the value of Opus Genetics, from analyzing the company fundamentals such as Shares Owned By Insiders of 16.14 %, return on equity of -0.64, and Current Valuation of (962.64 K) as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Opus Genetics,'s price fluctuation is extremely dangerous at this time. Calculation of the real value of Opus Genetics, is based on 3 months time horizon. Increasing Opus Genetics,'s time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Opus stock is determined by what a typical buyer is willing to pay for full or partial control of Opus Genetics,. Since Opus Genetics, is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Opus Stock. However, Opus Genetics,'s intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.11 | Real 0.95 | Hype 1.11 | Naive 1.15 |
The real value of Opus Stock, also known as its intrinsic value, is the underlying worth of Opus Genetics, Company, which is reflected in its stock price. It is based on Opus Genetics,'s financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Opus Genetics,'s stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Opus Genetics, helps investors to forecast how Opus stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Opus Genetics, more accurately as focusing exclusively on Opus Genetics,'s fundamentals will not take into account other important factors: Opus Genetics, Total Value Analysis
Opus Genetics, is currently projected to have company total value of (962.64 K) with market capitalization of 35.67 M, debt of 4.04 M, and cash on hands of . The negative valuation of Opus Genetics, may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial commitments of the company both on and off balance sheet. Investors should carefully check all of the Opus Genetics, fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(962.64 K) | 35.67 M | 4.04 M |
Opus Genetics, Investor Information
About 16.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.04. Some equities with similar Price to Book (P/B) outperform the market in the long run. Opus Genetics, recorded a loss per share of 1.09. The entity last dividend was issued on the 6th of November 2020. The firm had 1:4 split on the 6th of November 2020. Based on the key measurements obtained from Opus Genetics,'s financial statements, Opus Genetics, is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Opus Genetics, Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Opus Genetics, has an asset utilization ratio of 35.31 percent. This indicates that the Company is making USD0.35 for each dollar of assets. An increasing asset utilization means that Opus Genetics, is more efficient with each dollar of assets it utilizes for everyday operations.Opus Genetics, Ownership Allocation
Opus Genetics, owns a total of 31.57 Million outstanding shares. Opus Genetics, holds 16.14 pct. of its outstanding shares held by insiders and 16.64 pct. owned by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Opus Genetics, Profitability Analysis
The company reported the last year's revenue of 19.05 M. Reported Net Loss for the year was (9.99 M) with loss before taxes, overhead, and interest of (15.39 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Opus Genetics,'s worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Opus Genetics, and how it compares across the competition.
About Opus Genetics, Valuation
The stock valuation mechanism determines Opus Genetics,'s current worth on a weekly basis. Our valuation model uses a comparative analysis of Opus Genetics,. We calculate exposure to Opus Genetics,'s market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Opus Genetics,'s related companies.Opus Genetics, Growth Indicators
Investing in growth stocks can be very risky. If the company such as Opus Genetics, does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 24 M |
Complementary Tools for Opus Stock analysis
When running Opus Genetics,'s price analysis, check to measure Opus Genetics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Opus Genetics, is operating at the current time. Most of Opus Genetics,'s value examination focuses on studying past and present price action to predict the probability of Opus Genetics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Opus Genetics,'s price. Additionally, you may evaluate how the addition of Opus Genetics, to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |